Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: COVID-19 and cardiovascular pharmacotherapy Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by